Thiazole derivatives used as PI 3 kinase inhibitors

Details for Australian Patent Application No. 2008340053 (hide)

Owner Novartis AG

Inventors Fairhurst, Robin Alec; Furet, Pascal; Caravatti, Giorgio; Imbach, Patricia; Guagnano, Vito

Agent Davies Collison Cave

Pub. Number AU-A-2008340053

PCT Pub. Number WO2009/080694

Priority 07150228.0 20.12.07 EP

Filing date 18 December 2008

Wipo publication date 2 July 2009

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4168 (2006.01)

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/080694 Priority application(s): WO2009/080694

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008340055-Thermosetting polysaccharides

2008340051-Heat exchanger